MARKET

VRTX

VRTX

Vertex Pharmaceuticals Inc
NASDAQ
345.62
+0.47
+0.14%
Opening 10:01 10/04 EDT
OPEN
346.72
PREV CLOSE
345.15
HIGH
346.72
LOW
345.10
VOLUME
49.96K
TURNOVER
0
52 WEEK HIGH
367.00
52 WEEK LOW
282.21
MARKET CAP
89.20B
P/E (TTM)
26.72
1D
5D
1M
3M
1Y
5Y
3 No-Brainer Stocks to Buy With $1,000 Right Now
The Motley Fool · 7h ago
Positive Trial Results and Promising Cell Therapy Approach Bolster Buy Rating for Vertex Pharmaceuticals: An Analyst’s Perspective
TipRanks · 8h ago
Vertex updated data on diabetes candidate VX-880 encouraging
Seeking Alpha · 17h ago
Vertex Presents Updated VX-880 Results From Ongoing Phase 1/2 Study In Type 1 Diabetes
Benzinga · 18h ago
Top Analyst Reports for Berkshire Hathaway, Broadcom & Comcast
NASDAQ · 23h ago
2 Top Biotech Stocks to Buy in October
The Motley Fool · 1d ago
Revvity's (RVTY) New Launch to Widen Access to Editing Technology
NASDAQ · 2d ago
Got $1,000? 2 No-Brainer Stocks to Buy
The Motley Fool · 2d ago
More
About VRTX
Vertex Pharmaceuticals Incorporated is a global biotechnology company. The Company is focused on developing medicines that treat the underlying cause of cystic fibrosis (CF). Its pipeline includes mid- and late-stage clinical programs in sickle cell disease, beta thalassemia, acute and neuropathic pain, APOL1-mediated kidney disease, type 1 diabetes, and alpha-1 antitrypsin deficiency, and earlier-stage programs in diseases such as muscular dystrophies. Its marketed medicines are TRIKAFTA/KAFTRIO (elexacaftor/tezacaftor/ivacaftor and ivacaftor), SYMDEKO/SYMKEVI (tezacaftor/ivacaftor and ivacaftor), ORKAMBI (lumacaftor/ivacaftor) and KALYDECO (ivacaftor). The Company has a pipeline of investigational small molecule, cell and genetic therapies in other serious diseases where it has deep insight into causal human biology, including sickle cell disease, beta thalassemia, APOL1-mediated kidney disease, pain, type 1 diabetes, alpha-1 antitrypsin deficiency and Duchenne muscular dystrophy.

Webull offers kinds of Vertex Pharmaceuticals Incorporated stock information, including NASDAQ:VRTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VRTX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading VRTX stock methods without spending real money on the virtual paper trading platform.